title: Clinical implication of antiphospholipid antibodies in systemic lupus erythematosus.
authors.affiliation: Department of Nephrology, University of Turin, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Stratta
authors.forename: C
authors.initials: C
authors.lastname: Canavese
authors.forename: A
authors.initials: A
authors.lastname: Thea
authors.forename: G
authors.initials: G
authors.lastname: Tognarelli
authors.forename: M
authors.initials: M
authors.lastname: Dogliani
authors.forename: M C
authors.initials: MC
authors.lastname: Porcu
authors.forename: G
authors.initials: G
authors.lastname: Garis
authors.forename: A
authors.initials: A
authors.lastname: Borchiellini
authors.forename: P C
authors.initials: PC
authors.lastname: Schinco
authors.forename: A
authors.initials: A
authors.lastname: Vercellone
mesh_terms: D017152:Antibodies, Antiphospholipid / Q000097:blood*; D002493:Central Nervous System Diseases / Q000150:complications / Q000276:immunology; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000150:complications / Q000276:immunology*; D008181:Lupus Nephritis / Q000150:complications / Q000276:immunology; D010314:Partial Thromboplastin Time; D013921:Thrombocytopenia / Q000150:complications / Q000276:immunology; D013927:Thrombosis / Q000150:complications / Q000276:immunology
chemical_list: D017152:Antibodies, Antiphospholipid; D016682:Lupus Coagulation Inhibitor